Viewing entries tagged
Portfolio

Medbelle raises $7m (€6m) in Series A to Build World’s First Digital Hospital

Medbelle raises $7m (€6m) in Series A to Build World’s First Digital Hospital

  • Funding round led by signals Venture Capital, with other investors including Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and prior backer Cavalry Ventures

  • Announcement signals rapid expansion of ground-breaking, end-to-end digital patient care platform  

  • 30,000 Britons have already used new service to navigate their treatment journey, as founders on target to attract a further 144,000 users by 2020

  • Medbelle bringing greater efficiency and transparency to the previously fragmented and bureaucratic healthcare sector

London and Berlin,  April 2019 — Medbelle, the UK’s leading end-to-end platform for medical procedures, today announced $7m (€6m) in funding to accelerate the digitisation of the patient journey. The Series A funding round was led by signals Venture Capital and joined by Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and Cavalry Ventures.

Already covering the majority of the UK, and with its eye on international expansion, Medbelle’s three-layered ‘digital hospital’ model (Medbelle Platform, Medbelle Care, and Medbelle Operating System) places unprecedented control in the hands of patients, while giving healthcare professionals access to an integrated suite of management tools covering the entire treatment journey – from first consultation to billing, post-operative care and follow-up.

Patients book their procedure with Medbelle, which provides them with leading specialists and state-of-the-art operating facilities – with all organisation taken care of by the platform. The Medbelle service is designed to save them time, stress and money, ensuring that they benefit from the very best treatments and facilities available. Once a patient is registered, every aspect of their treatment is accessible via a single, simple web portal and app, or through their own personal Medbelle Care Adviser.

At the same time, the Medbelle Operating System ensures healthcare providers can make the most of their valuable time and resources. It allows specialists, hospitals and staff to work more productively, and liberates them from inefficient, unnecessary administrative tasks.    

Already enthusiastically backed by patients, with an outstanding Net Promoter Score (NPS) of 93 – making it the highest-rated medical provider in the UK – the cash injection will enable Medbelle to undertake the next phase of its roll-out. And with the UK private healthcare sector forecast to hit $13.8bn by 2023, it’s a market opportunity that has proven highly attractive to investors.

In its launch phase, Medbelle was focused on privately-paid (self-funded) procedures in areas such as cosmetics, bariatrics and ophthalmology and is currently expanding into orthopaedics and fertility. In the future, Medbelle will work with private medical and public insurance providers / the NHS to leverage its technology and services to help patients with all types of medical procedure.

“The new capital will accelerate the development of our platform while growing Medbelle’s operating footprint,” said Daniel Kolb, co-founder and MD of Medbelle. “It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients.”

Clemens Koós, investment manager at signals Venture Capital, said: “Major digital platforms improve customer experience in almost all industries, however, in healthcare, the digitisation of patient journeys has been heavily lagging behind until now. Medbelle’s technology and personalised care enable much simpler and more affordable medical treatments - while allowing healthcare providers to efficiently focus on treating patients. We look forward to working with the Medbelle team and co-investors in expanding the platform to include more treatment specialities and increasing its reach."

Vasile Foca, Managing Partner at Talis Capital, said: “The digital health market is expected to reach $536bn by 2025 – so the time is right to be focusing on technologies that can transform healthcare and the patient journey as we know it today. We’re proud to be backing Leander, Daniel and their high-quality team in this latest round as they roll out their truly digital treatment solution. Medbelle is the world’s first digital hospital that creates real value for both patients and providers and offers unrivalled care from some of the country’s best specialists.”

Leander de Laporte, co-founder and MD at Medbelle, said: “The ‘digital hospital’ creates real value for patients and healthcare providers alike and, therefore, can offer care from the best specialists in the country with a truly digital and personal experience. It’s great to have new partners on board who bring such vast experience to the table. We all agree that an integrated model enables much faster deployment of technology to improve patient experience and reduce costs.”

-Ends -

Contact: antonella@burlington.cc

About Medbelle: Medbelle is the first digital hospital - an end-to-end platform for medical procedures. We strive to create a world in which patients navigate their treatment journey digitally and receive personal care at the click of a button.
We have integrated the entire patient journey to deliver a frictionless treatment experience for patients: We hire surgeons, rent operating facilities and provide a platform to streamline patient data, communication, provider selection, treatment pricing, scheduling and more. At the same time, our platform reduces workload and optimises utilisation of specialist doctors and hospitals. Our technology, patient care team and high-quality hospitals & specialists have garnered an industry-leading Net Promoter Score of 93 and have allowed us to help more than 30,000 patients all over the UK. Visit medbelle.com for details.

About Talis Capital: Talis Capital is a venture capital investment firm that takes smart money from some of the world’s most successful entrepreneurs and business people and invests it strategically in early stage technology companies with global potential. Talis has invested over $500m worth of transactions since 2009 and the portfolio includes Darktrace, Onfido, iwoca, Pirate Studios, Luminance, Ynsect and Oh My Green. Focused on building long-term partnerships, Talis leverages its network to give some of the world’s most innovative startups opportunity to thrive. For more see www.taliscapital.com.

About signals Venture Capital: signals Venture Capital is an early stage investor backed by

a €100m venture capital fund with a focus on forward-looking, scalable technology solutions that can transform or disrupt entire industries. signals Venture Capital invests in companies active in disruptive industries such as health, mobility and financial services as well as b2b business models all over Europe and Israel, especially in the field of Data & Analytics, Artificial Intelligence and Internet of Things. The portfolio companies profit not only from the classic venture capital support but also from the extensive ecosystem with renowned German and European partners, industry experts and diverse distribution channels.

About IBB Beteiligungsgesellschaft: IBB Beteiligungsgesellschaft (www.ibb-bet.de) provides venture capital to innovative Berlin-based companies and has established itself as a market leader in the field of early-stage financing in Germany. The funds are used primarily for the development and market launch of innovative products or services, as well as for business concepts of creative industries. Currently, two of the funds managed by the IBB Beteiligungsgesellschaft are in the investment phase, the VC Fonds Technologie Berlin II with a fund size of 60 million euros and the VC Fonds Kreativwirtschaft Berlin II with a fund size of 40 million euros. Both VC funds are financed by means of the Investitionsbank Berlin (IBB) and the European Fund for Regional Development (EFRE) administered by the State Berlin. Since 1997 the IBB Beteiligungsgesellschaft, in consortia with partners, has made 1.43 billion euros available to creative and technology-orientated companies; thereof, the portion invested by IBB Beteiligungsgesellschaft itself, as lead, co-lead or co-investor, was approximately 200 million euros.

About Mutschler Ventures: Mutschler Ventures is the venture arm of a Zurich based family office, actively investing in start-up companies in the digital as well as blockchain world. Over the past years, Mutschler Ventures has been invested in e.g. Betreut.de, later care.com, Adyen, McMakler, Auto1, Sygnum, Loanboox and other companies in the German-speaking region.

About Cavalry Ventures: Cavalry Ventures is an entrepreneurially driven VC fund based in Berlin with a focus on angel and seed-stage investments in Europe. The six founding Partners have repeatedly financed, founded, built and sold market-leading companies such as Delivery Hero, Tradeshift or plista. Being both, experienced investors and still active entrepreneurs, the cavalry offers hands-on support and a strong value-add to ambitious founders of fast-growing technology companies.


Insurdata raises $3m in seed funding

Insurdata raises $3m in seed funding

PRESS RELEASE

·       Funding led by Anthemis and Menlo Ventures

·       Five new VC firms participate

·       Capital will support next stage in Insurdata development

London, April 2019 – Insurdata, the award-winning insurtech firm which specialises in the augmentation of peril-specific exposure and risk data via its Exposure Engine Platform, has today announced that it has secured $3 million from a group of investors, led by Anthemis and Menlo Ventures.

Insurdata_banner.png

The group of investors is composed of both Venture Capitalists and Angels and includes: Alma Mundi Fund, Talis Capital, InsurTech Gateway, Ascend, Prototype Capital and Baloise Group. Insurdata secured an initial tranche of funding of $1 million in October 2017.

Insurdata was launched in 2017 to address the lack of property-specific data available to the re/insurance market. The firm’s platform enables re/insurers to generate high-resolution, accurate, risk-specific data globally in real-time at all points in the underwriting workflow. This includes accurate geocode information, building attributes and first-floor elevation data.

By providing access to precise data, Insurdata aims to give underwriters greater confidence in modelled loss estimates and accumulation analyses, resulting in better risk selection and improved portfolio management. This in turn supports better, more accurately priced products, more resilient balance sheets and ultimately helps reduce volatility.

Commenting on the funding, Jason Futers, CEO, Insurdata, said: “We are delighted to have secured the backing of a fantastic range of investors who fully understand the criticality of the service that Insurdata provides to the re/insurance market. Our work to date has exposed material deficiencies in the quality and scope of information which underwriters are reliant upon, which in turn have a detrimental effect on their ability to accurately price risk and manage portfolios effectively.”

“Moving forward, we aim to capitalise on the fact that our Exposure Engine can be applied to any peril by working with re/insurers to introduce more refined data sets for a broad range of exposures, including flood, windstorm, earthquake, terrorism and cyber. We are also evolving the Insurdata Customer Portal to make access to high-resolution data as straightforward and speedy as possible.”

Ruth Foxe-Blader, Managing Director, Anthemis, said: “We are delighted to continue our support of Insurdata. As the re/insurance industry undergoes a period of readjustment in the aftermath of two major loss years, the quality and granularity of data that supports their underwriting decisions will be vital to their ability to manage volatility. The data consistency that Insurdata provides I believe will become an industry standard.”

Javier Santiso, Founder & CEO, Mundi, said: “Insurdata provides an excellent opportunity to invest in a company which has the potential to refine and enhance the lifeblood of the re/insurance industry – data. Few other markets are as reliant upon such incredibly complex and comprehensive data sets. Ensuring that such information is of the highest possible resolution required to enable underwriter to make risk decisions with confidence should be a top priority for every organisation.”

Richard Chattock, CEO, InsurTech Gateway, said: “InsurTech is making major inroads into virtually every phase of the insurance process. Insurdata targets the core component of that process – exposure data. In our view, the firm brings together the right expertise, the right technology and the right capabilities at exactly the right time to make a tangible difference to the insurance market.”

Tom Williams, Principal, Talis Capital, said: “We are very excited to be partnering with Jason and his impressive team as they continue to provide a pioneering approach to risk data capture for insurers worldwide. With over 90% of modelled loss estimates for flood exposures currently underestimated by traditional methods due to a lack of accurate first-floor elevation data[1],this solution has the potential to vastly improve insurer analysis accuracy and significantly reduce their costs. We look forward to working with Insurdata as they boost their sales power and refine the technology to meet the ever-growing demand in the market”

All media enquiries, please contact

Nigel Allen                                                                    Suzanne Hirst

Director, Allen & Clapham                                              Director, Allen & Clapham

M +44 (0)7988 478824                                                  M +44 (0)7988 140357

 

About Insurdata

Insurdata is an insurtech firm which intelligently creates, enhances, scores and transfers high-resolution, peril-specific exposure and risk data globally via its proprietary Exposure Engine platform. The company provides insurers and reinsurers with building-level property data delivered at the point-of-underwriting to enable more accurate pricing, and to support underwriting and risk assessment decisions. The data is generated using Insurdata’s Exposure Engine and accessed via API or the Insurdata Customer Portal.

For more information, visit www.insurdata.io or follow @insurdata

[1] Source: Insurdata

Portfolio Update - 24.11.2017

Onfido have been selected as the first ID verification provider for Salesforce's Financial Services Cloud where they will enable financial institutions to easily verify and onboard new customers. 

 

 

Shirley Chen, Founder & CEO of Narrativ, has been named in "Forbes 30 Under 30" following her impressive background where she acted as Head of Marketing at Moda Operandi before founding Narrativ, an advertising technology start-up which now handles 4.3 trillion monthly requests.
 

 

Luminance have won British Legal Technology Awards' "New IT Product of the Year" for their market-leading platform which continues to attract new clients including Chapman Tripp, New Zealand's largest full-service commercial law firm.